Structural Analysis of the Change-of-Function E120H Mutation in Human Liver △4-3-Ketosteroid 5β-Reductase (AKR1D1).

被引：0
|
作者：
Chen, M. [1 ]
Drury, J. E. [1 ]
Penning, T. M. [1 ]
Christianson, D. W.
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 17 条
  • [1] 5β-Reduced steroids and human Δ4-3-ketosteroid 5β-reductase (AKR1D1)
    Chen, Mo
    Penning, Trevor M.
    STEROIDS, 2014, 83 : 17 - 26
  • [2] Crystal structure of human liver Δ4-3-ketosteroid 5β-reductase (AKR1D1) and implications for substrate binding and catalysis
    Di Costanzo, Luigi
    Drury, Jason E.
    Penning, Trevor M.
    Christianson, David W.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (24) : 16830 - 16839
  • [3] Conversion of Human Steroid 5β-Reductase (AKR1D1) into 3β-Hydroxysteroid Dehydrogenase by Single Point Mutation E120H EXAMPLE OF PERFECT ENZYME ENGINEERING
    Chen, Mo
    Drury, Jason E.
    Christianson, David W.
    Penning, Trevor M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (20) : 16609 - 16622
  • [4] Crystal Structures of Human Δ4-3-Ketosteroid 5β-Reductase (AKR1D1) Reveal the Presence of an Alternative Binding Site Responsible for Substrate Inhibition
    Faucher, Frederick
    Cantin, Line
    Van Luu-The
    Labrie, Femand
    Breton, Rock
    BIOCHEMISTRY, 2008, 47 (51) : 13537 - 13546
  • [5] Crystal Structures of Human Δ4-3-Ketosteroid 5β-Reductase (AKR1D1) Reveal the Presence of an Alternative Binding Site Responsible for Substrate Inhibition, (vol 47, pg 13537, 2008)
    Faucher, Frederick
    Cantin, Line
    Luu-The, Van
    Labrie, Fernand
    Breton, Rock
    BIOCHEMISTRY, 2009, 48 (05) : 1144 - 1144
  • [6] Human Δ4-3-oxosteroid 5β-reductase (AKR1D1) deficiency and steroid metabolism
    Palermo, Mario
    Marazzi, Maria Grazia
    Hughes, Beverly A.
    Stewart, Paul M.
    Clayton, Peter T.
    Shackleton, Cedric H. L.
    STEROIDS, 2008, 73 (04) : 417 - 423
  • [7] Mutations in SRD5B1 (AKR1D1), the gene encoding Δ4-3-oxosteroid 5β-reductase, in hepatitis and liver failure in infancy
    Lemonde, HA
    Custard, EJ
    Bouquet, J
    Duran, M
    Overmars, H
    Scambler, PJ
    Clayton, PT
    GUT, 2003, 52 (10) : 1494 - 1499
  • [8] SRD5B1 (AKR1D1) gene analysis in Δ4-3-oxosteroid 5β-reductase deficiency:: evidence for primary genetic defect
    Gonzales, E
    Cresteil, D
    Baussan, C
    Dabadie, A
    Gerhardt, MF
    Jacquemin, E
    JOURNAL OF HEPATOLOGY, 2004, 40 (04) : 716 - 718
  • [9] Distinguishing primary from secondary Δ4-3-oxosteroid 5β-reductase (SRD5B1, AKR1D1) deficiency by urinary steroid analysis
    Yanagi, Tadahiro
    Mizuochi, Tatsuki
    Homma, Keiko
    Ueki, Isao
    Seki, Yoshitaka
    Hasegawa, Tomonobu
    Takei, Hajime
    Nittono, Hiroshi
    Kurosawa, Takao
    Matsuishi, Toyojiro
    Kimura, Akihiko
    CLINICAL ENDOCRINOLOGY, 2015, 82 (03) : 346 - 351
  • [10] Regulation of the human AKR1D1 (5β-reductase) gene;: a novel role for bile acids in modulating cortisol metabolism in chronic liver disease
    O'Flaherty, E.
    Walker, B.
    Andrew, R.
    SCOTTISH MEDICAL JOURNAL, 2008, 53 (01) : 52 - 52
12